Evaluation of interleukin 28B single nucleotide polymorphisms in infants suffering from bronchiolitis

Virus Research

Volumn 165, Issue 2, 2012, Pages 236-240

  Scagnolari, Carolina ^a   Midulla, Fabio ^b   Riva, Elisabetta ^c   Monteleone, Katia ^a   Solimini, Angelo ^b   Bonci, Enea ^b   Cangiano, Giulia ^b   Papoff, Paola ^b   Moretti, Corrado ^b   Pierangeli, Alessandra ^a   Antonelli, Guido ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY CAMPUS BIO MEDICO   (Italy)

Author keywords

Bronchiolitis; IFN; IL28B; Respiratory virus; RSV; Viral load

Indexed keywords

INTERLEUKIN 28B;

AGE; ARTICLE; BRONCHIOLITIS; CLINICAL FEATURE; DISEASE COURSE; DISEASE SEVERITY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; HOSPITALIZATION; INFECTION RISK; MEDICAL HISTORY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY SYNCYTIAL VIRUS INFECTION; SINGLE NUCLEOTIDE POLYMORPHISM; VIRUS LOAD;

BRONCHIOLITIS; FEMALE; GENOTYPE; HOSPITALIZATION; HUMANS; INFANT; INTERLEUKINS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; SEVERITY OF ILLNESS INDEX; VIRAL LOAD;

RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS;

EID: 84859442243     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2012.02.018     Document Type: Article

References (30)

1. Abe H., Hayes C.N., Ochi H., Tsuge M., Miki D., Hiraga N., Imamura M., Takahashi S., Kubo M., Nakamura Y., Kamatani N., Chayama K. Inverse association of IL28B genotype and liver mRNA expression of genes promoting or suppressing antiviral state. J. Med. Virol. 2011, 83:1597-1607.
2. Abe H., Hayes C.N., Ochi H., Maekawa T., Tsuge M., Miki D., Mitsui F., Hiraga N., Imamura M., Takahashi S., Kubo M., Nakamura Y., Chayama K. IL28 variation affects expression of interferon stimulated genes and peg-interferon and ribavirin therapy. J. Hepatol. 2011, 54:1094-1101.
3. Amanatidou V., Apostolakis S., Spandidos D.A. Genetic diversity of the host and severe respiratory syncytial virus-induced lower respiratory tract infection. Pediatr. Infect. Dis. J. 2009, 28:135-140.
4. Balagopal A., Thomas D.L., Thio C.L. IL28B and the control of hepatitis C virus infection. Gastroenterology 2010, 139:1865-1876.
5. Del Campo J.A., Maraver Zamora M., Ramýrez-Lorca R., Pardo-Yules B., Sáez M.E., Real L.M. IL28B polymorphism predicts sustained virological response in hepatitis C but is not associated with fibrosis or viral load. Hepatology 2010, 52:748A.
6. Dill M.T., Duong F.H., Vogt J.E., Bibert S., Bochud P.Y., Terracciano L., Papassotiropoulos A., Roth V., Heim M.H. Interferon-induced gene expression is a stronger predictor of treatment response than IL28B genotype in patients with hepatitis C. Gastroenterology 2011, 140:1021-1031.
7. Gad H.H., Hamming O.J., Hartmann R. The structure of human interferon lambda and what it has taught us. J. Interferon Cytokine Res. 2010, 30:565-571.
8. Ge D., Fellay J., Thompson A.J., Simon J.S., Shianna K.V., Urban T.J., Heinzen E.L., Qiu P., Bertelsen A.H., Muir A.J., Sulkowski M., McHutchison J.G., Goldstein D.B. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 2009, 461:399-401.
9. Honda M., Sakai A., Yamashita T., Nakamoto Y., Mizukoshi E., Sakai Y., Yamashita T., Nakamura M., Shirasaki T., Horimoto K., Tanaka Y., Tokunaga K., Mizokami M., Kaneko S. Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of IFN therapy for chronic hepatitis C. Gastroenterology 2010, 139:499-509. Hokuriku Liver Study Group.
10. Jewell N.A., Cline T., Mertz S.E., Smirnov S.V., Flaño E., Schindler C., Grieves J.L., Durbin R.K., Kotenko S.V., Durbin J.E. Lambda interferon is the predominant interferon induced by influenza A virus infection in vivo. J. Virol. 2010, 84:11515-11522.
11. Labarga P., Soriano V., Caruz A., Poveda E., Di Lello F., Hernandez-Quero J., Moreno S., Bernal E., Miró J.M., Leal M., Gutierrez F., Portilla J., Pineda J.A., CoRIS Association between IL28B gene polymorphisms and plasma HCV-RNA levels in HIV/HCV-co-infected patients. AIDS 2011, 25:761-766.
12. Lagging M., Askarieh G., Negro F., Bibert S., Söderholm J., Westin J., Lindh M., Romero A., Missale G., Ferrari C., Neumann A.U., Pawlotsky J.M., Haagmans B.L., Zeuzem S., Bochud P.Y., Hellstrand K. Response prediction in chronic hepatitis C by assessment of IP-10 and IL28B-related single nucleotide polymorphisms. PLoS One 2011, 6:e17232. DITTO-HCV Study Group.
13. Martin M.P., Qi Y., Goedert J.J., Hussain S.K., Kirk G.D., Hoots W.K., Buchbinder S., Carrington M., Thio C.L. IL28B polymorphism does not determine outcomes of hepatitis B virus or HIV infection. J. Infect. Dis. 2010, 202:1749-1753.
14. McHutchison J.G. The role of genetic markers in hepatitis C virus therapy: a major step for individualized care. Liver Int. 2011, 1:29-35.
15. Midulla F., Scagnolari C., Bonci E., Pierangeli A., Antonelli G., De Angelis D., Berardi R., Moretti C. Respiratory syncytial virus, human bocavirus and rhinovirus bronchiolitis in infants. Arch. Dis. Child. 2010, 95:35-41.
16. Mordstein M., Neugebauer E., Ditt V., Jessen B., Rieger T., Falcone V., Sorgeloos F., Ehl S., Mayer D., Kochs G., Schwemmle M., Günther S., Drosten C., Michiels T., Staeheli P. Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections. J. Virol. 2010, 84:5670-5677.
17. Papoff P., Moretti C., Cangiano G., Bonci E., Roggini M., Pierangeli A., Scagnolari C., Antonelli G., Midulla F. Incidence and predisposing factors for severe disease in previously healthy term infants experiencing their first episode of bronchiolitis. Acta Paediatr. 2011, 100:17-23.
18. Pierangeli A., Gentile M., Di Marco P., Pagnotti P., Scagnolari C., Trombetti S., Lo Russo L., Tromba V., Moretti C., Midulla F., Antonelli G. Detection and typing by molecular techniques of respiratory viruses in children hospitalized for acute respiratory infection in Rome, Italy. J. Med. Virol. 2007, 79:463-468.
19. Pierangeli A., Scagnolari C., Trombetti S., Grossi R., Battaglia M., Moretti C., Midulla F., Antonelli G. Human bocavirus infection in hospitalized children in Italy. Influenza Other Respir. Viruses 2008, 2:175-179.
20. Rallon N.I., Restrepo C., Naggie S., Lopez M., Del Romero J., Goldstein D., McHutchison J., Soriano V., Benito J.M. Interleukin-28B gene polymorphisms do not influence the susceptibility to HIV-infection or CD4 cell decline. AIDS 2011, 25:269-271.
21. Rauch A., Kutalik Z., Descombes P., Cai T., Di Iulio J., Mueller T., Bochud M., Battegay M., Bernasconi E., Borovicka J., Colombo S., Cerny A., Dufour J.F., Furrer H., Günthard H.F., Heim M., Hirschel B., Malinverni R., Moradpour D., Müllhaupt B., Witteck A., Beckmann J.S., Berg T., Bergmann S., Negro F., Telenti A., Bochud P.Y. Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study. Gastroenterology 2010, 138:338-1345. Swiss Hepatitis C., Cohort Study Swiss HIV Cohort Study.
22. Scagnolari C., Midulla F., Pierangeli A., Moretti C., Bonci E., Berardi R., De Angelis D., Selvaggi C., Di Marco P., Girardi E., Antonelli G. Gene expression of nucleic acid-sensing pattern recognition receptors in children hospitalized for respiratory syncytial virus-associated acute bronchiolitis. Clin. Vaccine Immunol. 2009, 16:816-823.
23. Scagnolari C., Midulla F., Trombetti S., Pierangeli A., Tromba V., Grossi R., Di Marco P., Dianzani C., Girardi E., Antonelli G. Upregulation of interferon-induced genes in infants with virus-associated acute bronchiolitis. Exp. Biol. Med. (Maywood) 2007, 232:1355-1359.
24. Suppiah V., Moldovan M., Ahlenstiel G., Berg T., Weltman M., Abate M.L., Bassendine M., Spengler U., Dore G.J., Powell E., Riordan S., Sheridan D., Smedile A., Fragomeli V., Müller T., Bahlo M., Stewart G.J., Booth D.R., George J. IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy. Nat. Genet. 2009, 41:1100-1104.
25. Tanaka Y., Nishida N., Sugiyama M., Kurosaki M., Matsuura K., Sakamoto N., Nakagawa M., Korenaga M., Hino K., Hige S., Ito Y., Mita E., Tanaka E., Mochida S., Murawaki Y., Honda M., Sakai A., Hiasa Y., Nishiguchi S., Koike A., Sakaida I., Imamura M., Ito K., Yano K., Asaki N., Sugauchi F., Izumi N., Tokunaga K., Mizokami M. Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat. Genet. 2009, 41:1105-1109.
26. Thomas D.L., Thio C.L., Martin M.P., Qi Y., Ge D., O'Huigin C., Kidd J., Kidd K., Khakoo S.I., Alexander G., Goedert J.J., Kirk G.D., Donfield S.M., Rosen H.R., Tobler L.H., Busch M.P., McHutchison J.G., Goldstein D.B., Carrington M. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 2009, 461:798-801.
27. Thompson A.J., Muir A.J., Sulkowski M.S., Ge D., Fellay J., Shianna K.V., Urban T., Afdhal N.H., Jacobson I.M., Esteban R., Poordad F., Lawitz E.J., McCone J., Shiffman M.L., Galler G.W., Lee W.M., Reindollar R., King J.W., Kwo P.Y., Ghalib R.H., Freilich B., Nyberg L.M., Zeuzem S., Poynard T., Vock D.M., Pieper K.S., Patel K., Tillmann H.L., Noviello S., Koury K., Pedicone L.D., Brass C.A., Albrecht J.K., Goldstein D.B., McHutchison J.G. Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus. Gastroenterology 2010, 139:120-129.
28. Urban T.J., Thompson A.J., Bradrick S.S., Fellay J., Schuppan D., Cronin K.D., Hong L., McKenzie A., Patel K., Shianna K.V., McHutchison J.G., Goldstein D.B., Afdhal N. IL28B genotype is associated with differential expression of intrahepatic interferon-stimulated genes in patients with chronic hepatitis C. Hepatology 2010, 52:1888-1896.
29. Vicencio A.G. Susceptibility to bronchiolitis in infants. Curr. Opin. Pediatr. 2010, 22:302-306.
30. Wainwright C. Acute viral bronchiolitis in children - a very common condition with few therapeutic options. Paediatr. Respir. Rev. 2010, 11:39-45.